Industry analysts expect M&A activity in the biotech space to accelerate in the back half of 2021 – and that could drive the ETF highlighted… Read More »This Biotech ETF Is “Prime Hunting Ground” For Big Pharma Companies Looking For Takeover Targets
While the biotech sector has outperformed the broader market over the past 12 months, investing in this sector can be risky. As such, the author… Read More »Assessing The Best Biotech ETFs
Given the volatility associated with the industry, when picking biotech stocks it may make sense to look to the best for ideas – and when… Read More »For The Best In Biotech, Look To The Baker Brothers
If you’re fortunate enough to not need your stimulus check to cover bills or basic needs, what stocks might you want to consider buying with… Read More »3 High-Growth Small-Cap Stocks For Your Stimulus Check
When it comes to exchange-traded funds to consider for the next year, today’s article highlights some ideas as identified by pros in the ETF industry,… Read More »Exchange Of Ideas: ETF Pros Share Their Top Funds For This Year
When it comes to recent talk of a rotation being underway into value stocks from growth stocks, the author of today’s article advises “Be skeptical… Read More »A “Four Pillars” Strategy For Identifying The Most Attractive Growth Stocks
After lagging growth for more than a decade, value appears to be staging a resurgence (or resurrection, given that it had been left for dead… Read More »3 ETFs To Play A Return To Value
Of the myriad of exchange-traded funds available to pick from, which are the best? The authors of today’s article narrow the universe of ETFs down… Read More »The Best ETFs In Every Category
You know the saying: Past performance is not indicative of future results. Over a decade ago, the SEC explicitly warned investors about this when it… Read More »How To Avoid Losing With “Winning” ETFs
Much has been written and said about who is winning and who is losing – politically or otherwise – in the current partial federal government… Read More »ETF Winners & Losers In The Government Shutdown Showdown